Search Results

Site Search

Robin Patel, M.D., and team study the use of transcriptomic-based cellular deconvolution to identify infectious and non-infectious causes of failed joint replacement surgeries - Insights

New research by Robin Patel, M.D. and others at Mayo Clinic has found that the use of a “transcriptomic-based cellular deconvolution tool” called CIBERSORTx could help improve the detection of infectious and non-infectious causes of failed...

Nailing the Suspect: The Prevalence of Autoimmune Encephalitis Compared with Infectious Encephalitis - Insights

For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.

Patient-focused pragmatism: The Mayo Clinic innovation model - Insights

In a world of ever-faster technical change, Mayo Clinic Laboratories is uniquely positioned to innovate. Collaboration with clinicians pinpoints unmet patient needs and facilitates the development of diagnostic testing that provides...

Detecting danger: Dan O'Bryan - Insights

Dan O’Bryan didn’t think his dizziness and lightheadedness were anything to worry about. Nearly 100 miles away, the team at Mayo Clinic that was remotely monitoring Dan’s heart could see the truth.

MML Prenatal Testing Brochure - MC2775-111

MML Prenatal Testing Brochure - PRENATAL TESTING COMPREHENSIVE SCREENING DIAGNOSTIC TESTING FETAL ABNORMALITIES WOMEN HEALTH CLINIC PRENATAL TESTING

MayoComplete - Insights

Learn about our menu of MayoComplete testing including a 515-gene panel and multiple disease-specific panels, which span the cancer spectrum.

Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody: Spencer Lodin - Insights

What started as a persistent headache for Spencer Lodin soon devolved into slowed speech, seizures, and hallucinations, symptoms which stumped ER doctors into thinking he had meningitis or was suffering from psychosis. Finally, specialized...

Frequently asked questions - Insights

For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...

Frequently asked questions - Insights

For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...

Syndromic Testing for Infectious Diseases: Respiratory Infections - Insights

In this month's "Hot Topic," Matthew Binnicker, Ph.D., discusses the use of multiplex panels for the diagnosis of respiratory infections and focuses on the clinical utility of these tests in the setting of upper respiratory tract...

What's New in Health Care Reform: Feb. 20 - Insights

Top highlights include: Flu shot kept about 50% from going to doctor, racial disparities in cancer incidence and survival rates are narrowing, having anesthesia once as a baby does not cause learning disabilities, personalized diet predicts...

Weather Preparedness: Hey, How's That Weather? - Insights

Weather always seems to be at the forefront of people's minds and discussions—especially in Minnesota. We are always commenting on needing more rain, that it’s too cold, or that a blizzard is on its way. Weather, however, is no trivial...

Hepatocellular Carcinoma Risk Panel with GALAD Score - Insights

In this “Hot Topic,” Joshua Bornhorst, Ph.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, reviews biomarker component testing for hepatocellular carcinoma, explains the GALAD score, and explores GALAD score...

Pathology consultation - Insights

Learn more about how Mayo Clinic Laboratories consultative pathology practice, which is supported by more than 100 board-certified pathologists, can provide expertise on any case.

H. pylori - Insights

Helicobacter pylori, or H. pylori, is one of the world’s most common chronic bacterial infections. Estimated to impact 4.4 billion individuals globally, H. pylori affects 35% to 89% of children, depending the on the geographic region in...

Autoimmune neurology evolution - Insights

Patients with autoimmune neurologic conditions deserve the best chance at an accurate diagnosis. These answers can make a real difference in a patient’s treatment and quality of life.

Meet Mukesh Pandey, Ph.D. - Developing a New Drug to Detect Prostate Cancer in Its Earliest Stages - Insights

Dr. Pandey is a nuclear radiology researcher working with a team to develop a new radioactive tracer to detect prostate cancer.

Week in Review: June 3 - Insights

Today's highlights include: Spread of monkeypox underscores need for physicians to be ready to understand, Pfizer completes application to FDA for vaccine for children under 5, and connect is key to supporting multiple sclerosis patients.

Demystifying the Tick with Bobbi Pritt, M.D. - Insights

The "Mpls-St Paul" magazine article highlights Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and Pathology, and her research on...

Hepatitis C Virus Genotypic Antiviral Drug Resistance [Test in Focus] - Insights

Joseph Yao, M.D., gives an overview of this new test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be...

Establishing a trusted lab partner in an evolving landscape - Insights

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, authored a Becker’s Healthcare article on how hospital laboratories can navigate times of change and uncertainty with the steadfast support...

Modified two-tiered testing for Lyme disease - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).

MCL - Blood Spot Collection Instructions (Spanish) - Brochure - MC4091-67SP

MCL - Blood Spot Collection Instructions (Spanish) - Brochure

Melanoma - Insights

Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.

Malabsorption disorders - Insights

Malabsorption syndrome encompasses several disorders that impact the ability of the small intestine to absorb macronutrients, micronutrients, or both. Because malabsorption syndrome can be caused by myriad factors, identifying the...

Liquid biopsy - Insights

Learn why liquid biopsy testing is a viable alternative to tissue-based biopsy testing for certain patients with cancer.

Mayo Clinic's Accurate Amyloidosis Typing Test Leads to Effective Treatment - Insights

When the type of amyloidosis is appropriately determined by accurate and effective laboratory testing, it can be treated properly.

Mayo Clinic Researchers Develop Prediction Tool for Kidney Stones - Insights

Mayo Clinic researchers are tracking the familiar characteristics of kidney stone formers in an online prediction tool that could help sufferers anticipate if they'll experience future episodes.

T-cell Lymphoma [Test in Focus] - Insights

Andrew Feldman, M.D., discusses the different tools and techniques Mayo Clinic Laboratories uses to accurately diagnose and classify T-cell lymphomas to help provide clinicians with the diagnostic answers they need to treat their patients.

Bobbi Pritt, M.D., Discusses Minnesota Bugs to Watch out for This Summer - Insights

In a recent article in the Star Tribune, Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory in Mayo Clinic’s Department of Laboratory Medicine and Pathology, weighs in on bugs present in Minnesota to watch out for this...

Week in Review: March 31 - Insights

Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.

Guidance on subtyping of influenza A test results - Insights

Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients

Reclaiming her joy: Joy Carol - Insights

A tenacious fighter, Joy Carol never lost hope that a mysterious condition that had stripped her of her ability to move would be identified. Hope turned into reality when a Mayo Clinic Laboratories test identified the cause of her illness...

A downward spiral undone: Jon Bratsch - Insights

Lying in an ICU bed as sick as he could get, Jon Bratsch thought he was past the point of no return. But when a Mayo Clinic Laboratories’ test revealed the source of his dire symptoms, everything changed. Today, Jon’s back to the life and...

Ceramide testing helps reduce risk of heart attack: Stephanie Blendermann - Insights

Her father was a heavy smoker who eventually needed bypass surgery for his clogged arteries, and three of her sisters died prematurely from heart attacks. So, as Stephanie Blendermann approached the age of 65, she had good reason to think...

Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights

An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...

Next-generation sequencing: Examining an often oversimplified & misunderstood technology-Part II - Insights

One of the biggest misunderstandings about genetic testing is a perception that once a variant is identified and analyzed thoroughly, using all the best tools available, it can be associated with a specific disease or condition. But many...

Autoimmune testing education - Insights

Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. Powered by expertise from our research labs, clinical labs, and Autoimmune Neurology Clinic, we have developed panels customized to address specific...

Michael Camilleri, M.D., and Leslie Donato, Ph.D., Discuss Testing for Bile Acid Malabsorption in Clinical Practice - Insights

In a recent issue of Mayo Clinic's Digestive Diseases, Michael Camilleri, M.D., a gastroenterologist at Mayo Clinic, and Leslie Donato, Ph.D., Co-Director for Cardiovascular Laboratory Medicine, Hospital Clinical Laboratory, and Point of...

Dr. Dong Chen and Dr. Sounak Gupta join Becker's Healthcare Podcast to discuss molecular testing in cancer care - Insights

Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the...

Week in Review: May 6 - Insights

Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision

On Demand - Insights

Online education and training provided through pre-recorded presentations and interactive learning modules.

MAG Antibody Testing [Test in Focus] - Insights

John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat...

Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D. - Insights

David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASSFIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the...

Pathways Case Studies: July 2020 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for July include the following sub-specialties: Bone and Soft Tissue & Pulmonary,...

Autoimmune evolution - Insights

Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. To better reflect this testing evolution, and to reduce confusion and improve utilization for our clients, effective April 28, we are renaming our...

QuantiFERON-TB Gold Plus - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.

Mayo Clinic Labs @Work: Shannon Bennett - Insights

As director of Regulatory Affairs for the Department of Laboratory Medicine and Pathology, Shannon Bennett helps safeguard Mayo Clinic’s reputation for quality care by ensuring that its clinical laboratories operate at the highest level of...

Mayo Clinic Labs @Work: Lisa Wortman Raring - Insights

In her role as a proposal writer, Lisa Wortman Raring helps show clients everything Mayo Clinic Laboratories has to offer, making it clear how the organization can best meet their needs and the needs of their patients.

Building a Scientific Collaborative Space - Insights

Combining innovative Mayo Clinic laboratories with medical businesses and creative start-up companies will help Rochester—and benefit patients.